Skip to content

the effect of nasal dexamethasone on post strabismus surgery nausea and vomiting prevention

Comparison of the effect of nasal dexamethasone on post strabismus surgery nausea and vomiting prevention in adults

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180416039326N12
Enrollment
60
Registered
2020-03-19
Start date
2020-04-04
Completion date
Unknown
Last updated
2020-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post operative nausea and vomiting. Nausea and vomiting

Interventions

Intervention 1: Intervention group: After receiving 5 ml / kg of ringer lactate and pre-oxygenation for patients, the same anesthetic induction was performed including Fentanyl 2mcg / kg, Propofol 2 m

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologists (ASA) Physical Status Classification 1 or 2 Age between 18 to 65 years Candidate for strabismus surgery filled informed consent form

Exclusion criteria

Exclusion criteria: patients with motion sickness taking anti emetic drugs during last 24 hours before surgery patient under treatment with opioid drugs smokers pregnant women

Design outcomes

Primary

MeasureTime frame
Incidence of nausea. Timepoint: 2 and 24 hours after entering recovery. Method of measurement: Visual Analogue Scale.;Score of nausea. Timepoint: 2 and 24 hours after entering recovery. Method of measurement: Visual Analogue Scale.;Incidence of vomiting. Timepoint: 2 and 24 hours after entering recovery. Method of measurement: scoring system for vomiting.;Score of vomiting. Timepoint: 2 and 24 hours after entering recovery. Method of measurement: scoring system for vomiting.;Incidence of pain. Timepoint: 2 and 24 hours after entering recovery. Method of measurement: Visual Analogue Scale.;Score of pain. Timepoint: 2 and 24 hours after entering recovery. Method of measurement: Visual Analogue Scale.;First time using anti emetic drug. Timepoint: 24 hours after entering recovery. Method of measurement: Clock.;Total dose of anti emetic. Timepoint: 24 hours after entering recovery. Method of measurement: file.;Total dose of analgesic. Timepoint: 24 hours after entering recovery. Method of measurement: file.;Frequency of using anti emetic drug. Timepoint: 24 hours after entering recovery. Method of measurement: file.;Extubation time. Timepoint: After Extubation. Method of measurement: Clock.;Length of stay in recovery. Timepoint: After exiting recovery. Method of measurement: Clock.;Patient satisfaction score. Timepoint: 24 hours after entering recovery. Method of measurement: Likert scale.;Beginning time of using liquid foods. Timepoint: after using liquid foods. Method of measurement: Clock.;Beginning time of using solid foods. Timepoint: after using solid foods. Method of measurement: Clock.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamidreza Shetabi

Esfahan University of Medical Sciences

hamidshetabi@med.mui.ac.ir+98 31 3445 2034

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026